论文部分内容阅读
卵巢癌在妇女因癌肿引起死亡中占第五位,在妇科恶性肿瘤引起死亡中占首位。尽管广泛应用了外科手术、放疗和化疗,卵巢癌病人的死亡率还是从1930年的4/100,000(妇女)逐渐增加到目前的10/100,000(妇女)器官部位深和缺乏早期症状使得卵巢癌的诊断发生困难。2/3病人直到局部或远处转移时才诊断出来。最有效的疗法也仅能减轻病情起到延长生命的作用。与其他肿瘤一样,增加卵巢癌病人生存率的最有效方法是早期诊断。多数这方面的努力是围绕着检测肿瘤相关抗原或肿瘤特异性抗原。此外,观察囊肿渗出物和外周血中各种酶、激素和抗体水平的改变也用作研究肿瘤的可能标志。
Ovarian cancer accounts for the fifth most common cause of cancer death in women, accounting for the highest proportion of deaths from gynecologic malignancies. Despite the widespread use of surgery, radiotherapy and chemotherapy, the mortality of patients with ovarian cancer is still increasing from 4 / 100,000 (women) in 1930 to 10 / 100,000 (women) in the current organ site, and the lack of early symptoms makes ovarian cancer Diagnosis is difficult. Two-thirds of the patients did not diagnose until local or distant metastasis. The most effective treatment can only reduce the role played by the disease to prolong life. Like other tumors, the most effective way to increase the survival rate of patients with ovarian cancer is early diagnosis. Most efforts in this area have centered around the detection of tumor-associated or tumor-specific antigens. In addition, observation of cyst exudates and changes in the levels of various enzymes, hormones and antibodies in the peripheral blood is also used as a possible marker for the study of tumors.